LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Improved Mass Spectrometric Method Presented for Proteomic Analyses

By LabMedica International staff writers
Posted on 25 Mar 2014
Image: The NanoACQUITY Ultra Performance Liquid Chromatograph (Photo courtesy of Waters Corporation).
Image: The NanoACQUITY Ultra Performance Liquid Chromatograph (Photo courtesy of Waters Corporation).
Mass spectrometry is a highly sensitive method of measurement of cell components or body fluids that has been used for the analysis of chemical and biological materials.

A proteome represents the entire set of proteins expressed by a cell and through analysis of proteomes, it is possible to obtain a comprehensive picture of the proteins and peptides present in cells or body fluids.

Scientists at the Johannes Gutenberg University (Mainz, Germany) have optimized the mass spectrometric workflow which allows the identification and significantly quantifies more proteins than before. They have perfected a relatively new, data-independent technique that facilitates a very accurate and reproducible quantitative analysis. The team focused in particular on developing novel techniques for quantitative proteomic analysis with the aid of so-called ion mobility mass spectrometry. This technique allows not only measuring the mass of a molecule but can also determine its cross section.

The investigators have also managed to enhance the technique known as label-free quantification. This eliminates the need for samples to be labeled in the laboratory before being analyzed, an otherwise complex procedure. Liquid chromatography-ion mobility separation-mass spectrometry (LC-IMS-MS) was performed using HeLa cell lysates. A software program for the integrated analysis of measurement data called ISOQuant has also been developed. This additional analytical dimension renders the technique optimally suited for the comprehensive investigation of highly complex samples.

Nanoscale separation of tryptic peptides was performed with a nanoACQUITY Ultra Performance Liquid Chromatography (UPLC) system (Waters Corporation, Milford, MA, USA) and mass spectrometric analysis of tryptic peptides was performed using a Synapt G2-S HDMS mass spectrometer, also from Waters Corporation. The average intensity of three most intense peptides strongly correlates with the absolute amount of their source protein. ISOQuant implements the quantification method, and additionally allows user-defined approaches, varying the number of peptides used for protein quantification.

Stefan Tenzer, PhD, an immunologist and the lead author of the study said, “We are now able to directly analyze patient samples and specific immune cells without prior cost-intensive preparation.” His colleagues added that the years of work within the technology platform have paid off in terms of a quantum leap forward with regard to the improvement of the technique of proteomic analysis mass spectrometry. The study was published in the March 2014 edition of the journal Nature Methods.

Related Links:

Johannes Gutenberg University
Waters Corporation


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Gel Cards
DG Gel Cards

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more